Systemic Solutions for Addressing Non-Communicable Diseases in Low- and Middle-Income Countries

Affiliations

27 July 2020

-

doi: 10.2147/JMDH.S252300


Abstract

Non-communicable diseases (NCDs) have been on the rise in low- and middle-income countries (LMICs) over the last few decades and represent a significant healthcare concern. Over 85% of "premature" deaths worldwide due to NCDs occur in the LMICs. NCDs are an economic burden on these countries, increasing their healthcare expenditure. However, targeting NCDs in LMICs is challenging due to evolving health systems and an emphasis on acute illness. The major issues include limitations with universal health coverage, regulations, funding, distribution and availability of the healthcare workforce, and availability of health data. Experts from across the health sector in LMICs formed a Think Tank to understand and examine the issues, and to offer potential opportunities that may address the rising burden of NCDs in these countries. This review presents the evidence and posits pragmatic solutions to combat NCDs.

Keywords: low- and middle-income countries; multisectoral; non-communicable diseases; public–private partnership; universal health coverage.

Conflict of interest statement

This article is based on the dialogue that occurred at the “Expert Forum on NCDs in Emerging Nations” convened by Pfizer in Dubai, UAE, 27–28 September 2019 and attended by all authors. Honoraria were provided by Pfizer to the external experts for their attendance at the meeting No author received an honorarium for the preparation of the article. Dr Amrit Ray, Dr Anurita Majumdar, Dr Barrett W Jeffers, Dr Kannan Subramaniam and Dr Shekhar Potkar are employees of Pfizer. The authors report no other conflicts of interest in this work. The views and opinions expressed in this article are those of the authors and do not represent or reflect in any way the official policy or position of their current or previous employers. Editorial and medical writing support was provided by Transform Medical Communications, which was funded by Pfizer. Mr Mathew Guilford reports personal fees from Common Health, Inc., during the conduct of the study; personal fees from Pfizer Upjohn, outside the submitted work. Dr Raghib Ali reports personal fees from Pfizer Upjohn, grants from Pfizer Upjohn, outside the submitted work. Dr Rayaz A Malik has attended advisory board to discuss NCD’s by pfizer, during the conduct of the study; and received grants from Pfizer, grants to support a consensus meeting on neurodegenerative disease from Biogen, personal fees from Novo Nordisk, personal fees from Aventis, outside the submitted work.


Figures


Similar articles

Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countries.

Essue BM, Laba M., Knaul F, Chu A, Minh HV, Nguyen TKP, Jan S.In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 6.PMID: 30212160 Free Books & Documents. Review.

Non-communicable diseases and health systems reform in low-and-middle-income countries.

Robinson HM, Hort K.Pac Health Dialog. 2012 Apr;18(1):179-90.PMID: 23240355

Health systems readiness for adopting mhealth interventions for addressing non-communicable diseases in low- and middle-income countries: a current debate.

Feroz A, Kadir MM, Saleem S.Glob Health Action. 2018;11(1):1496887. doi: 10.1080/16549716.2018.1496887.PMID: 30040605 Free PMC article.

The household economic burden of non-communicable diseases in 18 countries.

Murphy A, Palafox B, Walli-Attaei M, Powell-Jackson T, Rangarajan S, Alhabib KF, Avezum AJ, Calik KBT, Chifamba J, Choudhury T, Dagenais G, Dans AL, Gupta R, Iqbal R, Kaur M, Kelishadi R, Khatib R, Kruger IM, Kutty VR, Lear SA, Li W, Lopez-Jaramillo P, Mohan V, Mony PK, Orlandini A, Rosengren A, Rosnah I, Seron P, Teo K, Tse LA, Tsolekile L, Wang Y, Wielgosz A, Yan R, Yeates KE, Yusoff K, Zatonska K, Hanson K, Yusuf S, McKee M.BMJ Glob Health. 2020 Feb 11;5(2):e002040. doi: 10.1136/bmjgh-2019-002040. eCollection 2020.PMID: 32133191 Free PMC article.

Strengthening Primary Health-Care Services to Help Prevent and Control Long-Term (Chronic) Non-Communicable Diseases in Low- and Middle-Income Countries.

Haque M, Islam T, Rahman NAA, McKimm J, Abdullah A, Dhingra S.Risk Manag Healthc Policy. 2020 May 18;13:409-426. doi: 10.2147/RMHP.S239074. eCollection 2020.PMID: 32547272 Free PMC article. Review.


Cited by

Assessment of the WHO non-communicable diseases kit for humanitarian emergencies in South Sudan: a retrospective, prospective, observational study.

Alani AH, Miller L, Darji B, Waweru I, Atwiine AB, Tonelli M, Mogga JLK, Adams A, Ndinda L, Jongo S, Kiapi L.Confl Health. 2023 Jun 5;17(1):27. doi: 10.1186/s13031-023-00525-w.PMID: 37277827 Free PMC article.

The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses.

Marshall K, Beaden P, Durrani H, Tang K, Mogilevskii R, Bhutta Z.Int J Qual Stud Health Well-being. 2023 Dec;18(1):2156099. doi: 10.1080/17482631.2022.2156099.PMID: 36591948 Free PMC article. Review.

Inequalities in successful tobacco cessation and tobacco cessation attempts: Evidence from eight Sub-Saharan African countries.

Rossouw L, Filby S.PLoS One. 2022 Nov 22;17(11):e0277702. doi: 10.1371/journal.pone.0277702. eCollection 2022.PMID: 36413527 Free PMC article.

Research protocol for impact assessment of a project to scale up food policies in the Pacific.

Patay D, Trieu K, McKenzie B, Ramanathan S, Hure A, Bell C, Thow AM, Allender S, Reeve E, Palu A, Woodward M, Waqa G, Webster J.Health Res Policy Syst. 2022 Oct 29;20(1):117. doi: 10.1186/s12961-022-00927-x.PMID: 36309749 Free PMC article.

The burden of risk factors for non-communicable disease in rural Bihar, India: a comparative study with national health surveys.

Ross S, Chadha K, Mishra S, Lewington S, Shepperd S, Gathani T; NCDRI study collaborators.BMC Public Health. 2022 Aug 12;22(1):1538. doi: 10.1186/s12889-022-13818-1.PMID: 35962330 Free PMC article.


KMEL References


References

  1.  
    1. Non communicable diseases [homepage on the internet]. World Health Organization. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed February17, 2020.
  2.  
    1. The Global Economic Burden of Non-communicable Diseases [homepage on the internet]. Geneva: World Economic Forum. World Economic Forum. Available from: http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommu.... Accessed February17, 2020.
  3.  
    1. Guidance note on the integration of noncommunicable diseases into the united nations development assistance framework [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/nmh/ncd-task-force/guidance-note.pdf. Accessed October28, 2019.
  4.  
    1. Islam SM, Purnat TD, Phuong NT, Mwingira U, Schacht K, Fröschl G. Non-communicable diseases (NCDs) in developing countries: a symposium report. Global Health. 2014;10. doi:10.1186/s12992-014-0081-9 - DOI - PMC - PubMed
  5.  
    1. Stein DJ, Benjet C, Gureje O, et al. Integrating mental health with other non-communicable diseases. BMJ. 2019;364:l295. doi:10.1136/bmj.l295 - DOI - PMC - PubMed
  6.  
    1. Mental Health and Neurological Disorders [homepage on the internet] NCD Alliance. Available from: https://ncdalliance.org/why-ncds/ncd-management/mental-health-and-neurol.... Accessed February17, 2020.
  7.  
    1. Mascayano F, Armijo JE, Yang LH. Addressing stigma relating to mental illness in low- and middle-income countries. Front Psychiatry. 2015;6(38). doi:10.3389/fpsyt.2015.00038 - DOI - PMC - PubMed
  8.  
    1. Bennett JE, Stevens GA, Mathers CD; NCD Countdown 2030 collaborators. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet. 2018;392(10152):1072–1088. doi:10.1016/S0140-6736(18)31992-5 - DOI - PubMed
  9.  
    1. NCD countdown 2030 [homepage on internet]. Available from: http://www.ncdcountdown.org/. Accessed October30, 2019.
  10.  
    1. What legislators need to know [homepage on the internet]. World Health Organisation. Available from: https://www.undp.org/content/dam/undp/library/HIV-AIDS/NCDs/Legislators%.... Accessed February17, 2020.
  11.  
    1. Allen LN. Financing national non-communicable disease responses. Glob Health Action. 2017;10(1):1326687. doi:10.1080/16549716.2017.1326687 - DOI - PMC - PubMed
  12.  
    1. Outcome document of the High-Level Meeting of the General Assembly on the Comprehensive Review and Assessment of the Progress Achieved in the Prevention and Control of Non-communicable Diseases [homepage on the internet]. UN General Assembly; 2014. Available from: http://digitallibrary.un.org/record/774662/files/A_68_L.53-EN.pdf. Accessed May26, 2020.
  13.  
    1. Leading the Conversation on Noncommunicable Diseases Worldwide: an Evidence-Based Review of Key Research and Strategies to Develop Sustainable Solutions [homepage on internet]. Pfizer Upjohn. Available from: https://www.pfizer.com/upjohn_ncd_white_paper. Accessed May26, 2020.
  14.  
    1. Horton R. Offline: chronic diseases—the social justice issue of our time. Lancet. 2015;386(10011):2378. doi:10.1016/S0140-6736(15)01178-2 - DOI
  15.  
    1. Political Declaration of the High-level Meeting on Universal Health Coverage [homepage on the internet]. Available from: https://www.un.org/pga/73/wp-content/uploads/sites/53/2019/07/FINAL-draf.... Accessed February17, 2020.
  16.  
    1. Wu F, Guo Y, Chatterji S, et al. Common risk factors for chronic non-communicable diseases among older adults in China, Ghana, Mexico, India, Russia and South Africa: the study on global AGEing and adult health (SAGE) wave 1. BMC Public Health. 2015;15(1):88. doi:10.1186/s12889-015-1407-0 - DOI - PMC - PubMed
  17.  
    1. Parascandola M, Xiao L. Tobacco and the lung cancer epidemic in China. Transl Lung Cancer Res. 2019;8(Suppl 1):S21–S30. doi:10.21037/tlcr.2019.03.12 - DOI - PMC - PubMed
  18.  
    1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328(7455):1519. doi:10.1136/bmj.38142.554479.AE - DOI - PMC - PubMed
  19.  
    1. Pirie K, Peto R, Reeves GK, Green J, Beral V. Million Women Study Collaborators. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133–141. doi:10.1016/S0140-6736(12)61720-6 - DOI - PMC - PubMed
  20.  
    1. Sibai AM, Nasreddine L, Mokdad AH, Adra N, Tabet M, Hwalla N. Nutrition transition and cardiovascular disease risk factors in Middle East and North Africa countries: reviewing the evidence. Ann Nutr Metab. 2010;57(3–4):193–203. doi:10.1159/000321527 - DOI - PubMed
  21.  
    1. Value-based healthcare: A global assessment [homepage on the internet]. Economist Intelligence Unit. Available from: https://perspectives.eiu.com/sites/default/files/EIU_Medtronic_Findings-.... Accessed February17, 2020.
  22.  
    1. Chan JC, Lim LL, Luk AO, et al. From Hong Kong diabetes register to JADE program to RAMP-DM for data-driven actions. Diabetes Care. 2019;42(11):2022–2031. doi:10.2337/dci19-0003 - DOI - PubMed
  23.  
    1. Pourmohammadi K, Shojaei P, Rahimi H, Bastani P. Evaluating the health system financing of the Eastern Mediterranean Region (EMR) countries using Grey Relation Analysis and Shannon Entropy. Cost Eff Resour Alloc. 2018;16(1):1–9. doi:10.1186/s12962-018-0151-6 - DOI - PMC - PubMed
  24.  
    1. Health outcomes and cost: A 166-country comparison [homepage on the internet]. Economist Intelligence Unit. Available from: https://www.eiu.com/public/topical_report.aspx?campaignid=Healthoutcome2014. Accessed October30, 2019.
  25.  
    1. Arokiasamy P, Uttamacharya U, Jain K, et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal? BMC Med. 2015;13(1):1–16. doi:10.1186/s12916-015-0402-8 - DOI - PMC - PubMed
  26.  
    1. Adair T. Progress towards reducing premature NCD mortality - The Lancet Global Health. Lancet. 2018;6(12):E1254–E1255. - PubMed
  27.  
    1. 2018 United Nations High-Level Meeting on Non-communicable Diseases [homepage on the internet]. ESMO. Available from: https://www.esmo.org/policy/world-health-organization-united-nations/uni.... Accessed May26, 2020.
  28.  
    1. Allotey P, Davey T, Reidpath DD. NCDs in low and middle-income countries - assessing the capacity of health systems to respond to population needs. BMC Public Health. 2014;14(2):1–3. doi:10.1186/1471-2458-14-S2-S1 - DOI - PMC - PubMed
  29.  
    1. Tham TY, Tran TL, Prueksaritanond S, Isidro JS, Setia S, Welluppillai V. Integrated health care systems in Asia: an urgent necessity. Clin Interv Aging. 2018;13:2527–2538. doi:10.2147/CIA.S185048 - DOI - PMC - PubMed
  30.  
    1. Mendis S. The policy agenda for prevention and control of non-communicable diseases. Br Med Bull. 2010;96(1):23–43. doi:10.1093/bmb/ldq037 - DOI - PubMed
  31.  
    1. Know the NCD targets [homepage on the internet]. World Health Organization. Available from: https://www.who.int/beat-ncds/take-action/targets/en/. Accessed February17, 2020.
  32.  
    1. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to medications for cardiovascular diseases in low- and middle-income countries. Circulation. 2016;133(21):2076–2085. doi:10.1161/CIRCULATIONAHA.115.008722 - DOI - PMC - PubMed
  33.  
    1. UN High-Level Meeting on universal health coverage [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/news-room/events/detail/2019/09/23/default-calendar/.... Accessed October28, 2019.
  34.  
    1. Universal health coverage (UHC) [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/news-room/fact-sheets/detail/universal-health-covera...). Accessed February17, 2020.
  35.  
    1. Bos M, Agyemang C. Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC Public Health. 2013;13(1):387. doi:10.1186/1471-2458-13-387 - DOI - PMC - PubMed
  36.  
    1. Kotsiou O, Kotsios P, Srivastava D, Kotsios V, Gourgoulianis K, Exadaktylos A. Impact of the refugee crisis on the Greek healthcare system: a long road to Ithaca. Int J Environ Res Public Health. 2018;15(8):1790. doi:10.3390/ijerph15081790 - DOI - PMC - PubMed
  37.  
    1. Blanchet K, Fouad FM, Pherali T. Syrian refugees in Lebanon: the search for universal health coverage. Confl Health. 2016;10(1):1–5. doi:10.1186/s13031-016-0079-4 - DOI - PMC - PubMed
  38.  
    1. Van Minh H, Pocock NS, Chaiyakunapruk N, et al. Progress toward universal health coverage in ASEAN. Glob Health Action. 2014;7(1):25856. doi:10.3402/gha.v7.25856 - DOI - PMC - PubMed
  39.  
    1. Noncommunicable diseases and mental health: south East Asian Region [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/nmh/ncd-tools/who-regions-south-east-asia/en/. Accessed October25, 2019.
  40.  
    1. Myint CY, Pavlova M, Thein KN, Groot W. A systematic review of the health-financing mechanisms in the Association of Southeast Asian Nations countries and the People’s Republic of China: lessons for the move towards universal health coverage. PLoS One. 2019;14(6):e0217278. doi:10.1371/journal.pone.0217278 - DOI - PMC - PubMed
  41.  
    1. Joint Annual Health Review 2016 [homepage on the internet]. Vietnam Ministry of Health. Available from: http://jahr.org.vn/downloads/JAHR2016/JAHR2016_Edraft.pdf. Accessed February17, 2020.
  42.  
    1. Agustina R, Dartanto T, Sitompul R, et al. Universal health coverage in Indonesia: concept, progress, and challenges. Lancet. 2019;393(10166):75–102. doi:10.1016/S0140-6736(18)31647-7 - DOI - PubMed
  43.  
    1. Singh PK, Travis P. Universal health coverage in the World Health Organization South-East Asia Region: how can we make it “business unusual”? WHO South East Asia J Public Health. 2018;7:1–4. doi:10.4103/2224-3151.228420 - DOI - PubMed
  44.  
    1. Tackling NCDs: best buys [homepage on the internet]. World Health Organisation. Available from: https://apps.who.int/iris/bitstream/handle/10665/259232/WHO-NMH-NVI-17.9.... Accessed February17, 2020.
  45.  
    1. From Burden to “Best Buys”: reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/nmh/publications/best_buys_summary.pdf. Accessed February17, 2020.
  46.  
    1. Gilmore AB, Fooks G, Drope J, Bialous SA, Jackson RR. Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet. 2015;385(9972):1029–1043. doi:10.1016/S0140-6736(15)60312-9 - DOI - PMC - PubMed
  47.  
    1. Lebanon: needs assessment mission [homepage on the internet]. World Health Organisation. Available from: http://www.who.int/fctc/implementation/needs/factsheet-na-fctc-lebanon.pdf. Accessed February17, 2020.
  48.  
    1. Ambient air pollution [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/gho/phe/outdoor_air_pollution/en/. Accessed February17, 2020.
  49.  
    1. Robertson L, Nyamurungi KN, Gravely S, et al. Implementation of 100% smoke-free law in Uganda: a qualitative study exploring civil society’s perspective. BMC Public Health. 2018;18(1). doi:10.1186/s12889-018-5869-8. - DOI - PMC - PubMed
  50.  
    1. Workforce Resources for Health in Developing Countries [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/workforcealliance/media/KeyMessages_3GF.pdf. Accessed October25, 2019.
  51.  
    1. Bangdiwala SI, Fonn S, Okoye O, Tollman S. Workforce resources for health in developing countries. Public Health Rev. 2010;32(1):296–318. doi:10.1007/BF03391604 - DOI
  52.  
    1. Lim LL, Lau ES, Kong AP, et al. Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: a systematic review and meta-analysis. Diabetes Care. 2018;41(6):1312–1320. doi:10.2337/dc17-2010 - DOI - PMC - PubMed
  53.  
    1. Lemaire JB, Wallace JE. Burnout among doctors. BMJ. 2017;358:j3360. doi:10.1136/bmj.j3360 - DOI - PubMed
  54.  
    1. Long H, Huang W, Zheng P, et al. Barriers and facilitators of engaging community health workers in non-communicable disease (NCD) prevention and control in China: a systematic review (2006–2016). Int J Environ Res Public Health. 2018;15(11):2378. doi:10.3390/ijerph15112378 - DOI - PMC - PubMed
  55.  
    1. CSEM reflections on UHC global monitoring report [homepage on the internet]. Available from: https://www.uhc2030.org/fileadmin/uploads/uhc2030/Documents/Key_Issues/U.... Accessed February17, 2020.
  56.  
    1. Expert group meeting on the science‐policy interface summary [homepage on the internet]. Available from: https://sustainabledevelopment.un.org/content/documents/2075Summary%20of.... Accessed November6, 2019.
  57.  
    1. Approaches to establishing country-level multisectoral coordination mechanisms for the prevention and control of noncommunicable diseases [homepage on the internet]. World Health Organisation. Available from: http://www.searo.who.int/entity/noncommunicable_diseases/documents/ncd-m.... Accessed October30, 2019.
  58.  
    1. Heymann DL, Chen L, Takemi K, et al. Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet. 2015;385(9980):1884–1901. doi:10.1016/S0140-6736(15)60858-3 - DOI - PMC - PubMed
  59.  
    1. Zhang Y, Xu J, Li H, Cao B. A novel coronavirus (COVID-19) outbreak: a call for action. Chest. 2020;157(4):e99–e101. doi:10.1016/j.chest.2020.02.014 - DOI - PMC - PubMed
  60.  
    1. Walls H, Smith R, Cuevas S, Hanefeld J. International trade and investment: still the foundation for tackling nutrition related non-communicable diseases in the era of Trump? BMJ. 2019;365:I2217. doi:10.1136/bmj.l2217 - DOI - PMC - PubMed
  61.  
    1. CDC’s Vision for Public Health Surveillance in the 21st Century [homepage on the internet]. Centers for Disease Control. Available from: https://www.cdc.gov/mmwr/pdf/other/su6103.pdf. Accessed October25, 2019.
  62.  
    1. Findings from the Global Burden of Disease Study [homepage on the internet]. Institute for Health Metrics and Evaluation (IHME). Available from: http://www.healthdata.org/sites/default/files/files/policy_report/2019/G.... Accessed October 30, 2019.
  63.  
    1. IDF Diabetes Atlas 9th edition 2019 [homepage on the internet]. International Diabetes Federation. Available from: https://www.diabetesatlas.org/en/. Accessed February17, 2020.
  64.  
    1. Kroll M, Phalkey RK, Kraas F. Challenges to the surveillance of non-communicable diseases – a review of selected approaches. BMC Public Health. 2015;15(1). doi:10.1186/s12889-015-2570-z - DOI - PMC - PubMed
  65.  
    1. Sharma A. Global research priorities for noncommunicable diseases prevention, management, and control. Int J Non-Commun Dis. 2017;2:107–112.
  66.  
    1. Chia YC, Gray SY, Ching SM, Lim HM, Chinna K. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study. BMJ Open. 2015;5(5):e007324. doi:10.1136/bmjopen-2014-007324 - DOI - PMC - PubMed
  67.  
    1. WHO/ISH Cardiovascular Risk Prediction Charts Strengths and Limitations [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/cardiovascular_diseases/publications/cvd_qa.pdf. Accessed February17, 2020.
  68.  
    1. STEPS: A framework for surveillance [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/ncd_surveillance/en/steps_framework_dec03.pdf. Accessed October25, 2019.
  69.  
    1. Ramos-Cañizares IJ. E-Sakto: lowering the cardiovascular risk of patients with hypertension and diabetes through public–private partnership. KnE Social Sci. 2018;3(6):578. doi:10.18502/kss.v3i6.2406 - DOI
  70.  
    1. Joshi R, Alim M, Kengne AP, et al. Task shifting for non-communicable disease management in low and middle income countries – a systematic review. PLoS One. 2014;9(8):e103754. doi:10.1371/journal.pone.0103754 - DOI - PMC - PubMed
  71.  
    1. Fisher EB, Coufal MM, Parada H, et al. Peer support in health care and prevention: cultural, organizational, and dissemination issues. Annu Rev Publ Health. 2014;35. doi:10.1146/annurev-publhealth-032013-182450 - DOI - PubMed
  72.  
    1. Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems in the sustainable development goals era: time for a revolution. Lancet Glob Health. 2018;6(11):11. doi:10.1016/S2214-109X(18)30386-3 - DOI - PMC - PubMed
  73.  
    1. Beating non-communicable diseases in the community: the contribution of pharmacists [homepage on the internet]. International Pharmaceutical Federation. Available from: https://www.fip.org/files/content/publications/2019/beating-ncds-in-the-.... Accessed November8, 2019.
  74.  
    1. Bizri LE The role of the community pharmacists in non-communicable diseases: it is time for change. Proceedings of the 26th Annual Congress of Lebanese Order of Pharmacists; November 16–18, 2018; Beirut, Lebanon.
  75.  
    1. Primary Health Care Systems (PRIMASYS): comprehensive case study from Lebanon [homepage on the internet]. World Health Organisation. Available from: http://www.who.int/alliance-hpsr/projects/AHPSR-PRIMASYS-Lebanon-compreh.... Accessed February17, 2020.
  76.  
    1. Tuangratananon T, Wangmo S, Widanapathirana N, et al. Implementation of national action plans on noncommunicable diseases, Bhutan, Cambodia, Indonesia, Philippines, Sri Lanka, Thailand and Vietnam. Bull World Health Organ. 2018;97(2):129–141. doi:10.2471/BLT.18.220483 - DOI - PMC - PubMed
  77.  
    1. Marsiglia FF, Booth JM. Cultural adaptation of interventions in real practice settings. Res Soc Work Pract. 2015;25(4):423–432. doi:10.1177/1049731514535989 - DOI - PMC - PubMed
  78.  
    1. Global Tobacco Economics Consortium. The health, poverty, and financial consequences of a cigarette price increase among 500 million male smokers in 13 middle income countries: compartmental model study. BMJ. 2018;361:k1162. doi:10.1136/bmj.k1162 - DOI - PMC - PubMed
  79.  
    1. Malta DC, Oliveira TP, Luz M, Stopa SR, da Silva Junior JB, Dos Reis AA. Smoking trend indicators in Brazilian capitals, 2006–2013. Cien Saude Colet. 2015;20(3):631–640. doi:10.1590/1413-81232015203.15232014 - DOI - PubMed
  80.  
    1. Portes LH, Machado CV, Turci SR, Figueiredo VC, Cavalcante TM, Silva VL. Tobacco Control Policies in Brazil: a 30-year assessment. Cien Saude Colet. 2018;23:1837–1848. doi:10.1590/1413-81232018236.05202018 - DOI - PubMed
  81.  
    1. “Sin Tax” expands health coverage in the Philippines [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/features/2015/ncd-philippines/en/. Accessed November6, 2019.
  82.  
    1. Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues [homepage on the internet]. World Health Organisation. Available from: https://apps.who.int/iris/handle/10665/327434. Accessed October29, 2019.
  83.  
    1. Tools for implementing WHO PEN [homepage on the internet]. World Health Organisation. Available from: who.int/ncds/management/pen_tools/en/. Accessed October27, 2019.
  84.  
    1. Chang AY, Cowling K, Micah AE, et al. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050. Lancet. 2019;393(10187):2233–2260. doi:10.1016/S0140-6736(19)30841-4 - DOI - PMC - PubMed
  85.  
    1. Piot P, Caldwell A, Lamptey P, et al. Addressing the growing burden of non–communicable disease by leveraging lessons from infectious disease management. J Glob Health. 2016;6(1). - PMC - PubMed
  86.  
    1. Knaak S, Mantler E, Szeto A. Mental illness-related stigma in healthcare. Healthc Manage Forum. 2017;30(2):111–116. doi:10.1177/0840470416679413 - DOI - PMC - PubMed
  87.  
    1. Quinn CC, Swasey KK, Crabbe JCF, et al. The impact of a mobile diabetes health intervention on diabetes distress and depression among adults: secondary analysis of a cluster randomized controlled trial. JMIR mHealth uHealth. 2017;5(12):e183. doi:10.2196/mhealth.8910 - DOI - PMC - PubMed
  88.  
    1. Murthy N, Chandrasekharan S, Prakash MP, et al. The Impact of an mHealth voice message service (mMitra) on infant care knowledge, and practices among low-income women in india: findings from a pseudo-randomized controlled trial. Matern Child Health J. 2019;23(12):1658–1669. doi:10.1007/s10995-019-02805-5 - DOI - PMC - PubMed
  89.  
    1. Yang Q, Van Stee SK. The comparative effectiveness of mobile phone interventions in improving health outcomes: meta-analytic review. JMIR mHealth uHealth. 2019;7(4):e11244. doi:10.2196/11244 - DOI - PMC - PubMed
  90.  
    1. Dobe M. Health promotion for prevention and control of non-communicable diseases: unfinished agenda. Indian J Public Health. 2012;56(3):180. doi:10.4103/0019-557X.104199 - DOI - PubMed
  91.  
    1. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527–530. doi:10.1136/bmj.318.7182.527 - DOI - PMC - PubMed
  92.  
    1. Maneze D, Weaver R, Kovai V, et al. “Some say no, some say yes”: receiving inconsistent or insufficient information from healthcare professionals and consequences for diabetes self-management: A qualitative study in patients with Type 2 Diabetes. Diabetes Res Clin Pract. 2019;156(107830):107830. doi:10.1016/j.diabres.2019.107830 - DOI - PubMed
  93.  
    1. Vahdat S, Hamzehgardeshi L, Hessam S, Hamzehgardeshi Z. Patient involvement in health care decision making: a review. Iran Red Crescent Med J. 2014;16(1). doi:10.5812/ircmj.12454 - DOI - PMC - PubMed
  94.  
    1. Setia S, Ryan N, Nair PS, Ching E, Subramaniam K. Evolving role of pharmaceutical physicians in medical evidence and education. Adv Med Educ Pract. 2018;9:777–790. doi:10.2147/AMEP.S175683 - DOI - PMC - PubMed
  95.  
    1. Setia S, Tay JC, Chia YC, Subramaniam K. Massive open online courses (MOOCs) for continuing medical education – why and how? Adv Med Educ Pract. 2019;10:805–812. doi:10.2147/AMEP.S219104 - DOI - PMC - PubMed
  96.  
    1. De Martino I, D’Apolito R, McLawhorn AS, Fehring KA, Sculco PK, Gasparini G. Social media for patients: benefits and drawbacks. Curr Rev Musculoskelet Med. 2017;10(1):141–145. doi:10.1007/s12178-017-9394-7 - DOI - PMC - PubMed
  97.  
    1. Islam SM, Tabassum R, Liu Y, et al. The role of social media in preventing and managing non-communicable diseases in low-and-middle income countries: hope or hype? Health Policy Technol. 2019;8(1):96–101. doi:10.1016/j.hlpt.2019.01.001 - DOI
  98.  
    1. Kakkar AK, Sarma P, Medhi B. mHealth technologies in clinical trials: opportunities and challenges. Indian J Pharmacol. 2018;50(3):105–107. doi:10.4103/ijp.IJP_391_18 - DOI - PMC - PubMed
  99.  
    1. Ristau RA, Yang J, White JR. Evaluation and evolution of diabetes mobile applications: key factors for health care professionals seeking to guide patients. Diabetes Spectr. 2013;26(4):211–215. doi:10.2337/diaspect.26.4.211 - DOI
  100.  
    1. mHealth: new horizons for health through mobile technologies [homepage on the internet]. World Health Organisation. Available from: https://www.who.int/goe/publications/goe_mhealth_web.pdf. Accessed November6, 2019.
  101.  
    1. Joshi A, Rane M, Roy D, et al. Supporting treatment of people living with HIV/AIDS in resource limited settings with IVRs. Proceedings of the SIGCHI Conference on Human Factors in Computing Systems; April 2014; Toronto, Ontario, Canada.
  102.  
    1. Mohiuddin AK. Diabetes fact: Bangladesh perspective. Int J Diabetes Res. 2019;2(1):14–20.
  103.  
    1. Huckvale K, Wang CJ, Majeed A, Car J. Digital health at fifteen: more human (more needed). BMC Med. 2019;17(1):1–4. doi:10.1186/s12916-019-1302-0 - DOI - PMC - PubMed
  104.  
    1. Beran D, Pedersen HB, Robertson J. Noncommunicable diseases, access to essential medicines and universal health coverage. Glob Health Action. 2019;12(1):1670014. doi:10.1080/16549716.2019.1670014 - DOI - PMC - PubMed
  105.  
    1. Briggs AM, Persaud JG, Deverell ML, et al. Integrated prevention and management of non-communicable diseases, including musculoskeletal health: a systematic policy analysis among OECD countries. BMJ Glob Health. 2019;4(5):e001806. doi:10.1136/bmjgh-2019-001806 - DOI - PMC - PubMed
  106.  
    1. Mishra SR, Sharma A, Kaplan WA, Adhikari B, Neupane D. Liberating data to combat NCDs. Lancet Diabetes Endocrinol. 2016;4(6):482–483. doi:10.1016/S2213-8587(16)30054-7 - DOI - PubMed
  107.  
    1. Roshandel G, Khoshnia M, Poustchi H, et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases: a pragmatic cluster randomized controlled trial. Lancet. 2019;394:672–683. doi:10.1016/S0140-6736(19)31791-X - DOI - PubMed
  108.  
    1. Prevalence of tobacco smoking [homepage on the internet]. World Health Organization. Available from: https://www.who.int/gho/tobacco/use/en/. Accessed February17, 2020.
  109.  
    1. Escobar ER, Gamino MN, Salazar RM, et al. National trends in alcohol consumption in Mexico: results of the National Survey on Drug, Alcohol and Tobacco Consumption 2016–2017. Salud Ment. 2018;41(1):7–16.
  110.  
    1. Shamah-Levy T, Romero-Martínez M, Cuevas-Nasu L, Méndez Gómez-Humaran IM, Antonio Avila-Arcos M, Rivera-Dommarco JA. The Mexican National Health and Nutrition Survey as a Basis for Public Policy Planning: overweight and Obesity. Nutrients. 2019;11(8):1727. doi:10.3390/nu11081727 - DOI - PMC - PubMed